SOVEREIGN TRUST INSU

SOVRENINS
End-of-day quote. End-of-day quote  - 09/29
0.29NGN 0.00%
Valuation
Fiscal Period: December 2019 2020
Capitalization1 2 5022 273
Enterprise Value (EV)1 -3 487-3 687
P/E ratio 3,41x3,31x
Yield --
Capitalization / Revenue 0,34x0,28x
EV / Revenue -0,48x-0,45x
EV / EBITDA -4,12x-3,64x
Price to Book 0,29x0,26x
Nbr of stocks (in thousands) 12 511 23511 364 497
Reference price (NGN) 0,200,20
Announcement Date 06/15/202003/30/2021
Previous period Next period
1 NGN in Million
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2019 2020
Net sales1 7 3018 119
EBITDA1 8471 013
Operating profit (EBIT)1 693872
Operating Margin 9,49%10,7%
Pre-Tax Profit (EBT)1 819796
Net income1 503688
Net margin 6,89%8,47%
EPS2 0,060,06
Dividend per Share --
Announcement Date 06/15/202003/30/2021
Previous period Next period
1 NGN in Million
2 NGN
Finances - Leverage
Fiscal Period: December 2019 2020
Net Debt1 --
Net Cash position1 5 9895 960
Leverage (Debt / EBITDA) -7,07x-5,88x
Free Cash Flow1 192-67,9
ROE (Net Profit / Equities) 7,40%8,38%
Shareholders' equity1 6 8048 206
ROA (Net Profit / Asset) 3,50%3,86%
Assets1 14 38117 820
Book Value Per Share2 0,690,76
Cash Flow per Share2 0,630,64
Capex1 12,1128
Capex / Sales 0,17%1,58%
Announcement Date 06/15/202003/30/2021
Previous period Next period
1 NGN in Million
2 NGN
Price Earning Ratio
Change in Enterprise Value/EBITDA
EPS & Dividend